Global Journal of Cancer Therapy
Editorial
Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas
Non-Hodgkin's lymphomas (NHLs) are the second fastest growing cancer in
terms of incidence and deaths in the United States and Europe. NHLs are a
heterogeneous cancer group including several haematological neoplasias
with different degree of aggressiveness. In spite of the progresses,
conventional therapies do not ensure long-term survival [1].
http://www.peertechz.com/Cancer-Therapy/GJCT-1-102.php
Comments
Post a Comment